Teligent Weighs Sales Of Non-Core Assets

Seeking Funds To Unlock Potential Of New Injectables Facility

 
• By Aidan Fry
  
Time_To_Sell
Teligent is pondering selling off non-core assets • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products